Home Top Movers Akebia Therapeutics, Inc. (AKBA) Stock On the Rise Following Progression of Vadadastut’s...

Akebia Therapeutics, Inc. (AKBA) Stock On the Rise Following Progression of Vadadastut’s Commercial Development

Akebia Therapeutics, Inc. (AKBA) stock prices were up by a marginal 0.29% as of the market closing on May 28th, 2021, bringing the price per share up to USD$3.51 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 9.97%, bringing it up to USD$3.86.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

NDA Submission of Vadadustat

The biopharmaceutical giant and its collaborative partner, Otsuka Pharmaceutical Co., Ltd, announced on June 1st, 2022 that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug Application for vadadustat. Vadadustat is designed to treat anemia arising from chronic kidney disease (CKD) in adult patients both on dialysis, and otherwise.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Forecast of Development

The FDA has set a target action date of March 29th, 2022 for the Prescription Drug User Fee Act (PDUFA) and has assigned the application standard review. The FDA is not currently planning to conduct an Advisory Committee meeting to discuss the application. The acceptance of the NDA for vadadustat is a significant milestone for the collaborative duo, AKBA, and Otsuka, as the pair continue to develop a new oral treatment option to patients living with anemia arising from CKD.

Bright Future for Vadadustat

The company is confident in both the clarity of their data, and its quality, and looks forward to collaborating with the FDA during the application review. AKBA continues to work with its collaborative partners to ensure the company is well situated to facilitate a successful commercial launch of vadadustat, pending approval by the FDA.

Global Proliferation

Vadadustat is being developed for commercialization around the world by AKBA and Otsuka, with the treatment forecasted to proliferate the U.S, European, Chinese, Russian, Canadian Australian, Middle Eastern, and other territories. The two companies are also collaborating to prepare a Marketing Authorization Application for vadadustat that is forecasted to be submitted to the European Medicines Agency later in the fiscal year 2021.

Solid Liquidity Position

As of March 31st, 2021, AKBA reported cash, cash equivalents, and available-for-sale securities amounting to USD$272.8 million. The company anticipates allocating the cash resources towards the funding of its existing operating plan beyond the expected launch of vadadustat in the U.S. This forecast hinges on the timely regulatory approval of the treatment, as well as the receipt of associated reulgatory milestones.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for AKBA

Armed with a solid liquidity position, the company is keen to push forward with the commercization and global proliferation of vadadastut, thus ushering in further growth. Current and potential investors are hopeful that AKBA will continue to leverage the resources at its disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Edesa Biotech Inc. (EDSA) stock surged during current market trading. Here’s to know why?

Edesa Biotech Inc. (NASDAQ: EDSA) stock gained by 4.22% in the current market trading. Edesa Biotech is a clinical-stage biopharmaceutical business dedicated on the...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Cleveland BioLabs Inc. (CBLI) stock surged during after-hour session. Here’s what’s happening?

Cleveland BioLabs Inc. (NASDAQ: CBLI) stock declined by 3.58% at the last close while the CBLI stock price gains by 17.53% during the after-hour...

Why Ares Commercial Real Estate Corp (ACRE) stock plummeted on Thursday?

Ares Commercial Real Estate Corporation (ACRE) shares slipped 4.35% in after-hours on Thursday, June 17, 2021, and close the trading at $15.60. Earlier, ACRE's...

Nano-X Imaging Ltd. (NNOX) stock gained in the current market trading. Here’s to know why?

Nano-X Imaging Ltd. (NASDAQ: NNOX) stock gained by 14.90% in the current market trading. Nanox which is an Israeli company started by serial entrepreneur...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam